Generation Bio Q2 EPS $(0.47) Beats $(0.50) Estimate
Portfolio Pulse from Benzinga Newsdesk
Generation Bio (NASDAQ:GBIO) reported Q2 losses of $(0.47) per share, beating the analyst consensus estimate of $(0.50) by 6 percent. This represents a 28.79 percent increase over losses of $(0.66) per share from the same period last year.
August 04, 2023 | 12:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Generation Bio's Q2 earnings beat analyst estimates, showing a 28.79% improvement from the same period last year.
Generation Bio reported better than expected Q2 earnings, which is generally seen as positive news by investors. This could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100